-
Product Insights
DNA Polymerase Theta – Drugs In Development, 2023
Global Markets Direct’s DNA Polymerase Theta provides in depth analysis on DNA Polymerase Theta targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in DNA Polymerase Theta targeted therapeutics...
-
Product Insights
Protein Kinase C Theta Type – Drugs In Development, 2023
Global Markets Direct’s Protein Kinase C Theta Type provides in depth analysis on Protein Kinase C Theta Type targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Protein...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-4215 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-4215 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-4215 in...
-
Thematic Analysis
NewWeb3 – Thematic Intelligence
Web3 Thematic Report Overview Web3 is an ideology that refers to the next model of the internet built on blockchain. It promises a mix of peer-to-peer (P2P) communication channels and decentralized governance. This will lead the internet’s transition from an information-centric model to a user-centric model. Furthermore, Web3 aims to give users the ability to create, own, and monetize their content and manage the use of their data. However, it is still an emerging model and has a long way...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-101 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-101 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSK-101 in Solid Tumor Drug Details: GSK-101 are under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-6043 in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043 in Prostate Cancer Drug Details: ART-6043 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-6043 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043 in Solid Tumor Drug Details: ART-6043 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-6043 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-4524101 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-4524101 in Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSK-4524101 in Breast Cancer Drug Details: GSK-4524101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-4524101 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-4524101 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSK-4524101 in Solid Tumor Drug Details: GSK-4524101 is under development for...